메뉴 건너뛰기




Volumn 95, Issue 30, 2016, Pages

Treatment efficacy of anti-hypertensive drugs in monotherapy or combination: ATOM systematic review and meta-analysis of randomized clinical trials according to PRISMA statement

Author keywords

antihypertensive agent; hypertension; meta analysis; PRISMA statement; systemic review

Indexed keywords

AMLODIPINE PLUS OLMESARTAN; ANTIHYPERTENSIVE AGENT; FELODIPINE PLUS METOPROLOL; HYDROCHLOROTHIAZIDE PLUS OLMESARTAN; HYDROCHLOROTHIAZIDE PLUS VALSARTAN;

EID: 84982812961     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004071     Document Type: Review
Times cited : (62)

References (24)
  • 1
    • 84884403570 scopus 로고    scopus 로고
    • ESH/ESC Task Force for the Management of Arterial Hypertension-Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)
    • ESH/ESC Task Force for theManagement of Arterial Hypertension
    • ESH/ESC Task Force for the Management of Arterial Hypertension-Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for theManagement of Arterial Hypertension. J Hypertens 2013;31:1925-38.
    • (2013) J Hypertens , vol.31 , pp. 1925-1938
  • 2
    • 33947623101 scopus 로고    scopus 로고
    • Variability in response to antihypertensive drugs
    • Materson BJ. Variability in response to antihypertensive drugs. Am J Med 2007;120(4 Suppl 1):S10-20.
    • (2007) Am J Med , vol.120 , Issue.4 , pp. S10-20
    • Materson, B.J.1
  • 3
    • 4243595600 scopus 로고    scopus 로고
    • Predictors of systolic blood pressure control with antihypertensive monotherapy [abstract]
    • Campo C, Segura J, Guerrero L, et al. Predictors of systolic blood pressure control with antihypertensive monotherapy [abstract]. J Hypertens 2000;18(suppl 4):S41.
    • (2000) J Hypertens , vol.18 , pp. S41
    • Campo, C.1    Segura, J.2    Guerrero, L.3
  • 4
    • 77955934947 scopus 로고    scopus 로고
    • Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT trial
    • Gupta AK, Poulter NR, Dobson J, et al. Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT trial. Am J Hypertens 2010;23: 1023-30.
    • (2010) Am J Hypertens , vol.23 , pp. 1023-1030
    • Gupta, A.K.1    Poulter, N.R.2    Dobson, J.3
  • 5
    • 84880572277 scopus 로고    scopus 로고
    • Blood pressure response with fixed-dose combination therapy: Comparing hydrochlorothiazide with amlodipine through individual-level meta analysis
    • Agarwal R, Weir MR. Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta analysis. J Hypertens 2013;31:1692-701.
    • (2013) J Hypertens , vol.31 , pp. 1692-1701
    • Agarwal, R.1    Weir, M.R.2
  • 6
    • 6044236979 scopus 로고    scopus 로고
    • Systematic review: Antihypertensive drug therapy in black patients
    • Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: antihypertensive drug therapy in black patients. Ann Intern Med 2004; 141:614-27.
    • (2004) Ann Intern Med , vol.141 , pp. 614-627
    • Brewster, L.M.1    Van Montfrans, G.A.2    Kleijnen, J.3
  • 7
    • 84873704127 scopus 로고    scopus 로고
    • Effects of body size and hypertension treatments on cardiovascular event rates: Sub analysis of the ACCOMPLISH randomised controlled trial
    • Weber MA, Jamerson K, Bakris GL, et al. Effects of body size and hypertension treatments on cardiovascular event rates: sub analysis of the ACCOMPLISH randomised controlled trial. Lancet 2013;381:537-45.
    • (2013) Lancet , vol.381 , pp. 537-545
    • Weber, M.A.1    Jamerson, K.2    Bakris, G.L.3
  • 8
    • 14944342227 scopus 로고    scopus 로고
    • A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure
    • Baguet JP, Robitail S, Boyer L, et al. A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Am J Cardiovasc Drugs 2005;5:131-40.
    • (2005) Am J Cardiovasc Drugs , vol.5 , pp. 131-140
    • Baguet, J.P.1    Robitail, S.2    Boyer, L.3
  • 9
    • 34948816027 scopus 로고    scopus 로고
    • Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure
    • Baguet JP, Legallicier B, Auquier P, et al. Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Clin Drug Investig 2007;27:735-53.
    • (2007) Clin Drug Investig , vol.27 , pp. 735-753
    • Baguet, J.P.1    Legallicier, B.2    Auquier, P.3
  • 10
    • 12444279061 scopus 로고    scopus 로고
    • Hypertension guidelines, meta-analyses and clinical trials: Do we assume too much?
    • Peverill RE. Hypertension guidelines, meta-analyses and clinical trials: do we assume too much? Med J Aust 2005;182:82-4.
    • (2005) Med J Aust , vol.182 , pp. 82-84
    • Peverill, R.E.1
  • 11
    • 0030922816 scopus 로고    scopus 로고
    • Bias in meta-analysis detected by a simple, graphical test
    • Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
    • (1997) BMJ , vol.315 , pp. 629-634
    • Egger, M.1    Davey Smith, G.2    Schneider, M.3
  • 12
    • 84864371513 scopus 로고    scopus 로고
    • Evolution of heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analyses
    • Thorlund K, Imberger G, Johnston BC, et al. Evolution of heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analyses. PLoS One 2012;7:e39471.
    • (2012) PLoS One , vol.7 , pp. e39471
    • Thorlund, K.1    Imberger, G.2    Johnston, B.C.3
  • 15
    • 69449100622 scopus 로고    scopus 로고
    • Group PPreferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
    • Moher D, Liberati A, Tetzlaff J, et al. Group PPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
    • (2009) BMJ , vol.339 , pp. b2535
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3
  • 17
    • 84982811659 scopus 로고    scopus 로고
    • The R-INLA project. Accessed March 30
    • The R-INLA project. Bayesian computing with INLA! http://www. r-inla. org/. Accessed March 30, 2014.
    • (2014) Bayesian Computing with INLA
  • 18
    • 62849120031 scopus 로고    scopus 로고
    • Approximate Bayesian inference for latent Gaussian models using integrated nested Laplace approximations (with discussion)
    • Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models using integrated nested Laplace approximations (with discussion). J R Stat Soc 2009;71(Series B):319-92.
    • (2009) J R Stat Soc , vol.71 , pp. 319-392
    • Rue, H.1    Martino, S.2    Chopin, N.3
  • 19
    • 84893549987 scopus 로고    scopus 로고
    • 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)
    • James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20.
    • (2014) JAMA , vol.311 , pp. 507-520
    • James, P.A.1    Oparil, S.2    Carter, B.L.3
  • 20
    • 84859005287 scopus 로고    scopus 로고
    • Guideline Development GroupManagement of hypertension: Summary of NICE guidance
    • Krause T, Lovibond K, Caulfield M, et al. Guideline Development GroupManagement of hypertension: summary of NICE guidance. BMJ 2011;343:d4891.
    • (2011) BMJ , vol.343 , pp. d4891
    • Krause, T.1    Lovibond, K.2    Caulfield, M.3
  • 21
    • 84866326463 scopus 로고    scopus 로고
    • Antihypertensive effects of olmesartan compared with other angiotensin receptor blockers: A meta-analysis
    • Wang L, Zhao JW, Liu B, et al. Antihypertensive effects of olmesartan compared with other angiotensin receptor blockers: a meta-analysis. Am J Cardiovasc Drugs 2012;12:335-44.
    • (2012) Am J Cardiovasc Drugs , vol.12 , pp. 335-344
    • Wang, L.1    Zhao, J.W.2    Liu, B.3
  • 22
    • 84924254084 scopus 로고    scopus 로고
    • Blood Pressure Lowering Treatment Trialists' CollaborationEffects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: A meta-analysis of randomised trials
    • Ying A, Arima H, et al. Blood Pressure Lowering Treatment Trialists' CollaborationEffects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials. Lancet 2015;385:867-74.
    • (2015) Lancet , vol.385 , pp. 867-874
    • Ying, A.1    Arima, H.2
  • 23
    • 0035097086 scopus 로고    scopus 로고
    • ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension
    • Morgan TO, Anderson AI, MacInnis RJ. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. Am J Hypertens 2001;14:241-7.
    • (2001) Am J Hypertens , vol.14 , pp. 241-247
    • Morgan, T.O.1    Anderson, A.I.2    MacInnis, R.J.3
  • 24
    • 0033549296 scopus 로고    scopus 로고
    • Optimisation of antihypertensive treatment by crossover rotation of four major classes
    • Dickerson JE, Hingorani AD, Ashby MJ, et al. Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 1999;353:2008-13.
    • (1999) Lancet , vol.353 , pp. 2008-2013
    • Dickerson, J.E.1    Hingorani, A.D.2    Ashby, M.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.